896 abstracts found.



Results filter



The targets for tumour immunotherapy mediated by the inflammatory properties of vesicular stomatitis virus (VSV)-based antigen presentation depend upon the tumour’s anatomical site

Year:

Session type:

Richard Vile1,
1Mayo Clinic, Rochester, USA



Targeting immune checkpoints in cancer: new mechanistic insights

Year:

Session type:

Sergio A Quezada1,
1UCL Cancer Institute, University College London, London, UK



Co-targeting angiogenesis and immunosuppressive cell networks to improve anti-cancer therapy

Year:

Session type:

Michele De Palma1,
The Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland (1)



T cell immunosurveillance of healthy and transformed epithelia

Year:

Session type:

Adrian Hayday1,
1King's College London, London, UK



Neutrophil-derived signals promote initiation abilities of cancer stem cells during metastasis

Year:

Session type:

Ilaria Malanchi1,
1Cancer Research UK, London, UK



Introduction: High precision radiation therapy

Year:

Session type:

Diana Tait1,
1The Royal Marsden NHS Foundation Trust and The Royal College of Radiologists, London, UK



Progress in breast cancer prevention

Year:

Session type:

Jack Cuzick1,
1Queen Mary, University of London, London, UK



Stereotactic ablative radiotherapy (SABR): a local therapy poised to fight metastatic cancer

Year:

Session type:

Robert Timmerman1,
1University of Texas Southwestern Medical Center, Dallas, USA



Effects of aspirin on cancer incidence and metastasis

Year:

Session type:

Peter M Rothwell1,
1University of Oxford, Oxford, UK



Proton therapy: pushing the frontiers of radiotherapy

Year:

Session type:

Tony Lomax1,
1Centre for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland

Page 2 of 90« First...2...25...Last »